NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Domestic Credit Focus for Neo Alternative Asset Managers Amid Global Uncertainty

Bengaluru: In an era of heightened global geopolitical tensions, foreign investors are becoming increasingly cautious. However, Neo Alternative Asset Managers is bucking this trend by doubling down on domestic credit. The firm plans to raise ₹1,500-2,000 crore for its maiden real estate fund, a significant move that underscores its commitment to the domestic market.

The category-II alternative investment fund (AIF) will focus on providing credit to residential real estate developers across tier 1 and tier 2 cities. This strategic decision is expected to help the fund tap into the growing demand for housing in these regions.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Investor Takeaway

Investors may consider Neo Alternative Asset Managers' maiden real estate fund for potential returns.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.